Related Experiment Video
Updated: May 22, 2026

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
Diagnosis of acquired bone marrow failure syndrome during childhood using the 2008 World Health Organization
Wenyu Yang1, Peihong Zhang, Asahito Hama
1Diagnostic and Therapeutic Center of Children's Blood Disease, Blood Disease Hospital, Institute of Hematology, Chinese Academy of Medical Sciences, 288 Nanjing Road, Tianjin, China.
Insights
Differentiating pediatric aplastic anemia (AA) from refractory cytopenia (RCC/RCMD) is difficult. This study found RCC/RCMD patients had milder disease and bone marrow hypocellularity than AA patients, suggesting distinct clinical courses.
Area of Science:
- Pediatric Hematology
- Hematopathology
- Bone Marrow Failure Syndromes
Background:
- Distinguishing hypoplastic myelodysplastic syndromes from aplastic anemia (AA) presents diagnostic challenges.
- Accurate diagnosis is crucial for appropriate treatment and prognosis in pediatric bone marrow failure syndromes.
Purpose of the Study:
- To evaluate the diagnostic consensus for pediatric acquired bone marrow failure syndromes using WHO 2008 criteria.
- To compare clinical and laboratory findings between aplastic anemia and refractory cytopenia subtypes in children.
Main Methods:
- Joint review of bone marrow smears and trephine biopsies from 100 children with acquired bone marrow failure syndrome.
- Application of the 2008 World Health Organization classification criteria for hematopoietic and lymphoid tissues.
- Consensus diagnosis by Japanese and Chinese pediatric hematologists and pathologists.
Main Results:
- Consensus diagnoses included aplastic anemia (AA) in 29%, refractory cytopenia of childhood (RCC) in 58%, and refractory cytopenia with multilineage dysplasia (RCMD) in 13%.
- No significant differences in clinical/laboratory findings or diagnosis distribution were observed between Japanese and Chinese children.
- Patients diagnosed with RCC/RCMD exhibited milder disease severity and less bone marrow hypocellularity compared to those with AA.
Conclusions:
- The study established diagnostic consensus for pediatric bone marrow failure syndromes, identifying RCC/RCMD as distinct entities from AA.
- RCC/RCMD patients demonstrated a potentially milder clinical presentation than AA patients.
- Further prospective studies comparing clinical outcomes between AA and RCC groups are essential for establishing provisional entities for RCC.
Abstract:
Distinguishing hypoplastic myelodysplastic syndrome from aplastic anemia (AA) is challenging. In the present study, Japanese and Chinese pediatric hematologists and pathologists conducted a joint review of bone marrow (BM) smears and trephine biopsies in 100 children with acquired BM failure syndrome, using the criteria proposed in the 2008 edition of the World Health Organization classification of hematopoietic and lymphoid tissues. The final consensus for the diagnoses of 100 children was AA in 29 patients, refractory cytopenia of childhood (RCC) in 58 patients, and refractory cytopenia with multilineage dysplasia (RCMD) in 13 patients. No significant differences between Japanese and Chinese children were found with regards to clinical and laboratory findings, or the distribution of diagnoses. Patients with RCC/RCMD showed milder disease severity and BM hypocellularity than those with AA. To establish the provisional entities for RCC, it is essential to prospectively compare the clinical outcomes between AA and RCC groups in a large number of patients.
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
06:33Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia
Published on: November 10, 2023
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Heart Failure IV: Classification and Diagnostic Evaluation
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...